| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$10 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 11:25AM |
$0.018 |
$0.022 |
risen by
22.22%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Bio-Gene expanded mosquito vector control evaluation into Asia.
- Testing in Singapore aligned with WHO guidelines, targeting completion by Q4 2026.
- Bio-Gene aims to launch Qcide in Japan with Sumitomo Corporation.
- Raised $3.275 million to support Flavocide® and Qcide® programs.
- Reported cash balance of $1.94 million as of June 30, 2026.
- US patent allowed for Flavocide combinations, enhancing IP portfolio.
- Peter May received Envu Excellence Award for pest management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boresight Ltd (BST) ORDINARY FULLY PAID |
Industrials |
$45 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 11:25AM |
$0.290 |
$0.355 |
risen by
22.41%
|
|
BST - Price-sensitive ASX Announcement
Full Release
Key Points
- Boresight Ltd successfully listed on the ASX under the ticker code BST on 10 June 2026, raising A$8.0 million through an IPO.
- The company reported unaudited annual revenue of A$6.7 million for FY26, a 55% increase from the previous year.
- For the quarter ended 30 June 2026, Boresight achieved A$2.44 million in revenue.
- Cash and cash equivalents at the end of the period were approximately A$7.88 million with no debt.
- Boresight is engaged with the Australian Defence Force (ADF) Sovereign UAS Program, developing the BS-350 ISR drone.
- The company supports the ADF’s Project LAND 156 counter-drone program and secured a 12-month contract for BQ-400 target drones.
- Boresight expanded its market presence in Europe by delivering BQ-400 drones to an Italian customer.
- Post quarter, Boresight signed a lease for a new manufacturing facility in Huntsville, Alabama.
- The report details Boresight’s financial position, including significant cash inflows from financing activities.
- Boresight continues to focus on product development and expanding production capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$1,179 |
Cleansing Notice
|
31 Jul 2026 11:24AM |
$11.290 |
$12.100 |
risen by
7.17%
|
|
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$1,179 |
Cleansing Notice
|
31 Jul 2026 11:24AM |
$11.290 |
$12.100 |
risen by
7.17%
|
|
| Solaris Australian Equity Income Plus Limited (SET) ORDINARY FULLY PAID |
- |
$203 |
Initial monthly dividends
|
31 Jul 2026 11:23AM |
$2.180 |
$2.150 |
fallen by
1.38%
|
|
SET - Price-sensitive ASX Announcement
Full Release
Key Points
- Initial monthly dividends announced by Solaris Australian Equity Income Plus Limited.
- Dividends to start in August 2026 and increase through October 2026.
- First dividend of 0.3 cents in August, increasing to 0.7 cents by October.
- Dividends are fully franked, providing tax benefits to shareholders.
- Announcement aligns with objectives set during IPO in April 2026.
- Dividends subject to availability of profits, franking credits, and market conditions.
- Company aims to outperform income benchmarks while aligning with total return benchmarks.
- Management confident in sustaining dividend growth through strategic investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sagalio Energy Limited (SAN) ORDINARY FULLY PAID |
Energy |
$2 |
Quarterly Appendix 5B Cash Flow Report
|
31 Jul 2026 11:23AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
SAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash inflow from operating activities was $20,000.
- Proceeds from borrowings amounted to $74,000.
- Cash and cash equivalents at quarter end were $24,000.
- A $400,000 unsecured loan facility was available, with $27,000 drawn.
- Estimated cash availability covers 19.85 quarters of operations.
- Report complies with ASX Listing Rules and was approved by the board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Echelon Resources Limited (ECH) ORDINARY FULLY PAID |
Energy |
$78 |
Quarterly Activities Report
|
31 Jul 2026 11:23AM |
$0.350 |
$0.350 |
fallen by
0%
|
|
ECH - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed divestment of Cue Energy through Horizon Oil's takeover offer.
- Received more than A$17 million in cash proceeds.
- Echelon now holds a 6.64% shareholding in Horizon Oil.
- Strong cash flows with receipts up 11.3% from last quarter.
- Executed Kupe and Palm Valley Joint Venture Gas Supply Agreements.
- Debt repayments of A$19 million were made during the quarter.
- Palm Valley drilling program commenced on 25 July 2026.
- Echelon's cash balance was A$25 million as of 30 June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sagalio Energy Limited (SAN) ORDINARY FULLY PAID |
Energy |
$2 |
Quarterly Activities Report
|
31 Jul 2026 11:23AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
SAN - Price-sensitive ASX Announcement
Full Release
Key Points
- 443 tons of oil produced in the quarter.
- Sales revenue of US$125,318 recorded.
- Specialized oilfield service operator employed for efficiency.
- Steady oil production and sales operations.
- Unchanged economic interest in oil projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 11:23AM |
$0.018 |
$0.019 |
risen by
5.56%
|
|
ALV - Price-sensitive ASX Announcement
Full Release
Key Points
- Alvo Minerals reported promising drilling results from Palma VMS Cu/Zn Project.
- Significant intercepts include high-grade copper equivalent (CuEq) measurements.
- Continuous mineralization identified along approximately 1 km of strike.
- Future plans include further surveys to refine exploration targets.
- Financial reports indicate adequate cash flow for ongoing exploration activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Credit Income Trust (MA1) ORDINARY UNITS FULLY PAID |
- |
$555 |
Daily Estimate NTA for 30.07.2026
|
31 Jul 2026 11:21AM |
$1.990 |
$1.985 |
fallen by
0.25%
|
|
| Altoro Metals Limited (ARO) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 11:21AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
ARO - Price-sensitive ASX Announcement
Full Release
Key Points
- Rebranding to Altoro Metals Limited with ASX ticker ARO.
- Advancement of the Novales-Udías Zinc Project with historical data integration.
- Confirmation of high-grade zinc mineralization at Novales-Udías.
- Planning and commencement of a maiden diamond drilling program at Guajaraz Project.
- Successful $5 million capital raising to fund exploration activities.
- Strengthened financial position to support active drilling campaigns.
- Engagement with regional government and stakeholders for project advancement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$48 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 11:19AM |
$0.013 |
$0.011 |
fallen by
15.38%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive Phase 2b trial results for RAD 101 with 93% of patients meeting the primary endpoint.
- Planned Phase 3 trial for RAD 101 to begin in Q4 2026.
- Raised $12.5 million through institutional offer and initiated a $6 million Share Purchase Plan.
- Net cash outflows of $14.97 million for the quarter, mainly due to R&D and staff costs.
- Closing cash balance of $4.1 million at the end of the quarter.
- RAD 204 showed promising early clinical signs with a RECIST-confirmed Partial Response.
- Ongoing clinical programs include six active trials covering diagnostic and therapeutic applications.
- The company expects to continue operations with current financial strategies and potential capital raises.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Katana Capital Limited (KAT) ORDINARY FULLY PAID |
Financials |
$45 |
Change of Director's Interest Notice D Gooding
|
31 Jul 2026 11:19AM |
$1.370 |
$1.410 |
risen by
2.92%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$95 |
Monthly Report to Trustee and ASIC
|
31 Jul 2026 11:17AM |
$0.680 |
$0.675 |
fallen by
0.74%
|
|
| JPMorgan US 100Q Equity Premium Income Active ETF (Managed Fund) (JPEQ) |
Financials |
$97 |
Product Disclosure Statement - 31 July 2026
|
31 Jul 2026 11:14AM |
$59.200 |
$60.770 |
risen by
2.65%
|
|
| Environmental Clean Technologies Limited (ECT) ORDINARY FULLY PAID |
Industrials |
$43 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 11:14AM |
$0.135 |
$0.120 |
fallen by
11.11%
|
|
ECT - Price-sensitive ASX Announcement
Full Release
Key Points
- Expanded license agreement with Rice University to include Flash Joule Heating (FJH) for PFAS-contaminated adsorbents.
- Completed construction of the pilot-scale Rapid Electrothermal Mineralisation (REM) system.
- Lodged a public comment to the U.S. EPA regarding PFAS destruction and disposal.
- Commenced process to list ECT shares on the OTCQB Venture Market.
- Engaged RSM Corporate Australia Pty Ltd for a review of COLDry technology commercialization.
- Held an Extraordinary General Meeting on 17 July 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$482 |
Continuation of Suspension from Quotation
|
31 Jul 2026 11:14AM |
$0.125 |
$0.120 |
fallen by
4%
|
|
DTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Continuation of suspension from quotation under ASX Listing Rule 17.3.1
- Initial suspension under Listing Rule 17.2 on 29 July 2026
- Pending release of a market sensitive announcement
- Suspension remains until suitable announcement is released
- Reinstatement of securities depends on the announcement
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sportshero Limited (SHO) ORDINARY FULLY PAID |
Communication Services |
$46 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 11:13AM |
$0.035 |
$0.050 |
risen by
42.86%
|
|
SHO - Price-sensitive ASX Announcement
Full Release
Key Points
- Sportshero Limited focused on higher-margin subscriber acquisition in Q4 FY2026.
- Steady subscriber sign-up rates with a shift to higher-value options.
- Cash receipts were $285k, with $3.45m cash at quarter's end.
- Expanded agreement with XLSMART for HeroPlay platform distribution.
- Appointment of Duane Mutu as Gaming & Product Strategy Advisor.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$56 |
Becoming a substantial holder
|
31 Jul 2026 11:09AM |
$0.308 |
$0.350 |
risen by
13.82%
|
|
| Gwardar Resources Limited (GRS) ORDINARY FULLY PAID |
Materials |
$16 |
Gwardar Resources Lists On ASX
|
31 Jul 2026 11:06AM |
n/a |
$0.530 |
n/a
|
|
| McLaren Minerals Limited (MML) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 11:03AM |
$0.012 |
$0.014 |
risen by
16.67%
|
|
MML - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of McLaren Titanium Project drilling campaign.
- Substantial resource upgrade with high-grade intersections.
- Successful Share Purchase Plan raised A$1.65 million.
- Cash on hand at quarter end: A$2.625 million.
- Awaiting transfer of Barossa Zircon Project tenements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$5 |
Response to ASX Appendix 3Y Query
|
31 Jul 2026 11:02AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| Canyon Resources Ltd (CAY) ORDINARY FULLY PAID |
Materials |
$103 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
31 Jul 2026 11:02AM |
$0.049 |
$0.050 |
risen by
2.04%
|
|
CAY - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of static and dynamic tests on locomotives for ore transport.
- Minim Martap Project contains over 1.1 billion tonnes of high-grade bauxite.
- Investments in rail and port infrastructure in Cameroon to support logistics.
- Cash equivalents at the end of the quarter stood at $45.8 million.
- Net cash used in operating activities was $3.8 million, and investing activities were $63.6 million.
- Proceeds from financing activities helped offset cash outflows with $35.2 million net inflow.
- Project development aligns with Definitive Feasibility Study confirming long-term viability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$23 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 10:59AM |
$0.016 |
$0.014 |
fallen by
12.50%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurotech focuses on NTI164 development for autism spectrum disorder.
- Quarterly cash outflows were approximately $1.9 million.
- The company had $2.4 million in cash at quarter-end.
- Secured $3.15 million from a loan against R&D tax incentives.
- Received FDA IND clearance for NTI164.
- Progressing Phase 3 trial and expanding NTI164 Authorised Prescriber Program.
- Engaging with regulatory bodies and progressing US patent applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$17 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2026 10:59AM |
$0.345 |
$0.310 |
fallen by
10.14%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash received in operating activities was $0.1 million for the quarter.
- Cash receipts amounted to $6.5 million, higher than the previous quarter.
- Investing activities consumed $0.2 million, with $0.2 million allocated to capitalized software.
- Financing activities used $0.4 million, reducing debt to $0.25 million as of June 30, 2026.
- The company expects to exceed FY25 Underlying EBITDA and be cash positive for FY26.
- Software revenue growth is anticipated to outpace the previous fiscal year.
- Major contract secured with a public tender in Mexico, contributing significantly to ARR.
- The Aquila+ platform is crucial for new contracts and software deployments.
- Company's software ARR at $11.75 million by June 2026.
- Focus is on AI-integrated radiology deployments and expansion in international markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
